Education
About Us
Working with TipRanks
Follow Us
Lite Strategy (LITS)
NASDAQ:LITS
LITS Stock Chart & Stats
$1.67
--
Market closed
$1.67
--
Day’s Range― - ―
52-Week Range$1.46 - $9.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)622.79K
Market Cap
$70.63M
Enterprise Value$61.22M
Total Cash (Recent Filing)$10.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Feb 05, 2026EPS EstimateN/A
Last Dividend Ex-Date
Nov 16, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding36,785,397
10 Day Avg. Volume591,066
30 Day Avg. Volume622,792
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.78
Price to Sales (P/S)0.00
P/FCF Ratio-1.45
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-16.82
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lite Strategy News
LITS FAQ
What was Lite Strategy’s price range in the past 12 months?
Lite Strategy lowest stock price was $1.46 and its highest was $9.00 in the past 12 months.
What is Lite Strategy’s market cap?
Lite Strategy’s market cap is $70.63M.
When is Lite Strategy’s upcoming earnings report date?
Lite Strategy’s upcoming earnings report date is Feb 05, 2026 which is in 59 days.
How were Lite Strategy’s earnings last quarter?
Lite Strategy released its earnings results on Nov 17, 2025. The company reported -$0.124 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.124.
Is Lite Strategy overvalued?
According to Wall Street analysts Lite Strategy’s price is currently Overvalued.
Does Lite Strategy pay dividends?
Lite Strategy pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Lite Strategy dividends here
What is Lite Strategy’s EPS estimate?
Lite Strategy’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lite Strategy have?
Lite Strategy has 36,785,397 shares outstanding.
What happened to Lite Strategy’s price movement after its last earnings report?
Lite Strategy reported an EPS of -$0.124 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.941%.
Which hedge fund is a major shareholder of Lite Strategy?
Currently, no hedge funds are holding shares in LITS
Lite Strategy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 64.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $22.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.5%
Last 30 Days ▲ 7.5%
Last 30 Days ▲ 7.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.39%
12-Months-Change
Fundamentals
Return on Equity
-16.88%
Trailing 12-Months
Asset Growth
308.42%
Trailing 12-Months
Company Description
Lite Strategy
MEI Pharma, Inc. is a pharmaceutical company focused on the clinical development of oncology therapies. The company is dedicated to advancing a pipeline of drug candidates for the treatment of cancer, with a particular emphasis on hematologic malignancies. MEI Pharma's core products include investigational drugs intended to improve outcomes for patients with cancer, often through novel mechanisms of action or unique therapeutic approaches.
Technical Analysis
ABVC BioPharma
―
Jasper Therapeutics
―
Prelude Therapeutics
―
Gain Therapeutics
―
Estrella Immunopharma
―
Ownership Overview
0.28% Insiders
1.19% Mutual Funds
10.68% Other Institutional Investors
85.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---